Preoperative Micronized Flavonoid Fraction (MFF) Use in Multimodal Anesthesia in Anorectal Surgery

NACompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

November 25, 2021

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
HemorrhoidsHemorrhoid PainHemorrhoidal Bleeding
Interventions
DRUG

micronized flavonoid fraction

"Patients of the experimental group received Detralex® 1000 mg QD for 15 days before the operation, 3000 mg starting from day 1 after the surgery for 4 days, then 2000 mg for the next 3 days and 1000 mg till day 30 after surgery.~Under spinal anesthesia appropriate surgical intervention was performed. After the surgery, the patient was given a questionnaire and a scale for assessing pain at rest and during defecation within the first 2 weeks after surgery. During the hospital stay, the nurse filled out a section on the drugs used; after discharge, the patient filled out this section for 7 days after the surgery. After 30 days, the side effects section was filled out, and the quality of life was assessed on days 7 and 30. Also, the patients indicated in a separate column on which day after the surgery they were able to return to normal living or go to work."

Trial Locations (1)

119991

Lomonosov Moscow State University, Fundamental Medicine Faculty, Moscow

All Listed Sponsors
lead

"Center of Endourology Endocenter"

OTHER

NCT05772351 - Preoperative Micronized Flavonoid Fraction (MFF) Use in Multimodal Anesthesia in Anorectal Surgery | Biotech Hunter | Biotech Hunter